Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mass Balance Study of [14C]HSK39297 in Healthy Chinese Males
NCT06852092Phase 1Completed
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Start
- Sep 2024
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ciprocopan in paroxysmal nocturnal hemoglobinuria (PNH), sponsored by Haisco Pharmaceutical Group Co., Ltd. Primary endpoints: Recovery of total radioactivity in urine and fecal samples, Total radioactivity in plasma PK and 1 more. Started Sep 2024; status: completed.
02
Drugs
ciprocopan
03
Conditions
paroxysmal nocturnal hemoglobinuria (PNH)
Beyond the preview
Go deeper on NCT06852092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06852092.